NCT03812406

Brief Summary

This study aims to compare two techniques for performing a cesarean delivery: Misgav Ladach versus French Ambulatory Cesarean Section (FAUCS). The second techniques has been claimed to reduce post-operative pain, the need for analgesics, and reduce the time for ambulation. Such comparison has not been done so far, and this study will examined if indeed the FAUCS techniques offers any advantages.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2018

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 19, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 19, 2018

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 23, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 19, 2019

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 19, 2019

Completed
Last Updated

January 23, 2019

Status Verified

December 1, 2018

Enrollment Period

1 year

First QC Date

December 19, 2018

Last Update Submit

January 19, 2019

Conditions

Keywords

cesarean

Outcome Measures

Primary Outcomes (1)

  • Composite maternal adverse outcome

    The rate of women with a composite maternal adverse outcome, defined as at least one of the following: Visual Analogue Scale score \>6 (scale of 1-10, 1 being a very mild pain, 10 being the worst pain imagineable) at 3-4 hours post surgery, inability to ambulate 3-4 hours post surgery, and QoR15 (Quality of Recovery) score \< 90 (range 0 to 150, 150 being the best recovery after surgery) at 24 hours post surgery

    24 hours post surgery

Secondary Outcomes (5)

  • Length of surgery

    24 hours

  • Blood loss (ml) during surgery

    24 hours

  • Birthweight

    immediately after birth

  • Cord pH

    immediately after birth

  • Birth trauma

    24 hours

Study Arms (2)

FAUCS

EXPERIMENTAL

Patients undergoing a cesarean section using the FAUCS technique

Procedure: French Abulatory Cesrean Section

Control

ACTIVE COMPARATOR

Patients undergoing a cesarean section using the traditional (Misgav-Ladach) technique

Procedure: Misgav-Ladach

Interventions

A cesarean section performed according to the FAUCS technique

FAUCS
Misgav-LadachPROCEDURE

A cesarean section performed according to the Misgav Ladach technique

Control

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patients scheduled for a cesarean section
  • term pregnancy: 37-42 weeks
  • singleton pregnancy
  • age 18 and above
  • patients capable of signing an informed consent

You may not qualify if:

  • multiple pregnancy
  • emergency cesarean
  • previous 3 cesareans and above
  • placenta accreta
  • uterine myomas in the lower segment
  • fetal growth restriction
  • fetal anemia
  • preeclampsia
  • women scheduled for general anesthesia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Bnai-Zion Medical Center

Haifa, Israel

RECRUITING

Related Publications (1)

  • Sagi S, Bleicher I, Bakhous R, Pelts A, Talhamy S, Caspin O, Sammour R, Sagi-Dain L. Comparison between the modified French AmbUlatory Cesarean Section and standard cesarean technique-a randomized double-blind controlled trial. Am J Obstet Gynecol MFM. 2023 Jul;5(7):100910. doi: 10.1016/j.ajogmf.2023.100910. Epub 2023 Feb 23.

MeSH Terms

Conditions

Pain, PostoperativeMobility Limitation

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 19, 2018

First Posted

January 23, 2019

Study Start

August 19, 2018

Primary Completion

August 19, 2019

Study Completion

September 19, 2019

Last Updated

January 23, 2019

Record last verified: 2018-12

Locations